ArthroCare 2Q Revenue Hits $91.7M, Up 0.5%

Josh SandbergAugust 6, 2012

529 Less than a minute

ArthroCare‘s second quarter revenue reached $97.1 million, indicated a 0.5 percent increase over the same quarter last year.

Worldwide sales of ArthroCare’s sports medicine products increased $0.6 million or 1 percent.

Josh Sandberg

Josh Sandberg is the President and CEO of Ortho Spine Partners and sits on several company and industry related Boards. He also is the Creator and Editor of OrthoSpineNews.

ArthroCare 2Q Revenue Hits $91.7M, Up 0.5%

Josh Sandberg

Impact of a Novel Patient-Specific, Patient-Matched Bezier Parametric Curve Rod Platform on Proximal Junction Biomechanics in an in Silico Thoracolumbar Fusion Model

Spinal Alignment Solutions Announces FDA 510(k) Clearance for the Pelvic Incidence (PI) Rod System

Curiteva Surpasses 2,000 Procedures with Inspire®C Cervical Trabecular PEEK™ with HAFUSE® Technology

Josh Sandberg

Related Articles

SI-BONE, Inc. Reports Financial Results for the Third Quarter 2024 and Updates Guidance

Orthobiologics Market Is Expected To Reach a Revenue Of USD 11.7 Bn By 2033, at 5.7% CAGR: Dimension Market Research

Spine Surgery Products Market Size to Hit USD 20.0 Billion by 2031 at a 4.5% CAGR, Driven by Robotic and Computer-Assisted Innovations |Says Transparency Market Research, Inc.

SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results

Impact of a Novel Patient-Specific, Patient-Matched Bezier Parametric Curve Rod Platform on Proximal Junction Biomechanics in an in Silico Thoracolumbar Fusion Model

Spinal Alignment Solutions Announces FDA 510(k) Clearance for the Pelvic Incidence (PI) Rod System

Curiteva Surpasses 2,000 Procedures with Inspire®C Cervical Trabecular PEEK™ with HAFUSE® Technology